We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Cayman 8-Azaadenosine, 5mg
Product Description
Axitinib-13C-d3 is intended for use as an internal standard for the quantification of axitinib (Item No. ) by GC- or LC-MS. Axitinib (Item No. ) is a VEGFR inhibitor (IC50s = 1.2, 0.25, and 0.29 nM for VEGFR1, -2, and -3, respectively). It also inhibits c-Kit and PDGFRβ (IC50s = 1.7 and 1.6 nM, respectively). It inhibits VEGF-induced migration of and tube formation by human umbilical vein endothelial cells (HUVECs). Axitinib (1-100 mg/kg) reduces microvessel density, a marker of angiogenesis, and tumor growth in MV522 colon carcinoma, A375 melanoma, SN12C-GFP renal carcinoma, and U87 glioma mouse xenograft models in a dose-dependent manner. Formulations containing axitinib have been used in the treatment of renal cell carcinoma.
WARNING This product is not for human or veterinary use.
Technical Information
- AG-013736-13C-d3
- Acetonitrile: soluble
- DMSO: soluble
- Methanol: soluble
Shipping & Storage Information
| SKU | CAYM-34622-5 |
|---|---|
| Featured | No |
| Supplier Part Number | 34622-5 |
| UM | EA |
| UNSPSC | 12352200 |
| Manufacturer | Cayman |
| MSDS URL | Click here |
| Temperature | -20 |
| Refrigerated-Frozen | Refrigerated |
| CountryOfOrigin | China |
| ProductLine | CAYM |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 2 |
| Hazardous | N |
| CAS Number | 10299-44-2 |
| Energy Star | No |
| Green | No |
| ACT Ecolabel | No |
| Controlled | N |